Literature DB >> 10704076

Aspirin and some other nonsteroidal anti-inflammatory drugs inhibit cystic fibrosis transmembrane conductance regulator protein gene expression in T-84 cells.

D Tondelier1, F Brouillard, J Lipecka, R Labarthe, M Bali, M A Costa de Beauregard, T Torossi, M Cougnon, A Edelman, M Baudouin-Legros.   

Abstract

Cystic fibrosis (CF) is caused by mutations in the CF gene, which encodes CF transmembrane conductance regulator protein (CFTR), a transmembrane protein that acts as a cAMP-regulated chloride channel The disease is characterized by inflammation but the relationship between inflammation, abnormal transepithelial ion transport, and the clinical manifestations of CF are uncertain. The present study was undertaken to determine whether three nonsteroidal anti-inflammatory drugs (NSAIDs) (aspirin, ibuprofen, and indomethacin) modulate CFTR gene expression in T-84 cells. Treatment with NSAIDs reduced CFTR transcripts, and decreased cAMP-stimulated anion fluxes, an index of CFTR function. However, the two phenomena occurred at different concentrations of both drugs. The results indicate that NSAIDs can regulate both CFTR gene expression and the function of CFTR-related chloride transport, and suggest that NSAIDs act via multiple transduction pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10704076      PMCID: PMC1781806          DOI: 10.1080/09629359990388

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  24 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Nonsteroidal anti-inflammatory drugs alter chloride and fluid transport in bovine retinal pigment epithelium.

Authors:  S Bialek; J N Quong; K Yu; S S Miller
Journal:  Am J Physiol       Date:  1996-04

3.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

4.  Cystic fibrosis phenotype associated with pancreatic insufficiency does not always reflect the cAMP-dependent chloride conductive pathway defect. Analysis of C225R-CFTR and R1066C-CFTR.

Authors:  P Fanen; R Labarthe; F Garnier; M Benharouga; M Goossens; A Edelman
Journal:  J Biol Chem       Date:  1997-11-28       Impact factor: 5.157

5.  Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.

Authors:  Z Dong; C Huang; R E Brown; W Y Ma
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

6.  PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.

Authors:  C Jiang; A T Ting; B Seed
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

7.  Ibuprofen inhibits cystic fibrosis transmembrane conductance regulator-mediated Cl- secretion.

Authors:  D C Devor; B D Schultz
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

8.  Basal expression of the cystic fibrosis transmembrane conductance regulator gene is dependent on protein kinase A activity.

Authors:  R A McDonald; R P Matthews; R L Idzerda; G S McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

9.  Effect of high-dose ibuprofen in patients with cystic fibrosis.

Authors:  M W Konstan; P J Byard; C L Hoppel; P B Davis
Journal:  N Engl J Med       Date:  1995-03-30       Impact factor: 91.245

Review 10.  Biosynthesis and degradation of CFTR.

Authors:  R R Kopito
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

View more
  5 in total

1.  Acute regulation of the SLC26A3 congenital chloride diarrhoea anion exchanger (DRA) expressed in Xenopus oocytes.

Authors:  Marina N Chernova; Lianwei Jiang; Boris E Shmukler; Clifford W Schweinfest; Paola Blanco; Steven D Freedman; Andrew K Stewart; Seth L Alper
Journal:  J Physiol       Date:  2003-03-21       Impact factor: 5.182

2.  Changes in ion transport in inflammatory disease.

Authors:  Michael Eisenhut
Journal:  J Inflamm (Lond)       Date:  2006-03-29       Impact factor: 4.981

3.  New use for an old drug: COX-independent anti-inflammatory effects of sulindac in models of cystic fibrosis.

Authors:  Jérémy Rocca; Sylvie Manin; Anne Hulin; Abdel Aissat; Wilfried Verbecq-Morlot; Virginie Prulière-Escabasse; Adeline Wohlhuter-Haddad; Ralph Epaud; Pascale Fanen; Agathe Tarze
Journal:  Br J Pharmacol       Date:  2016-04-21       Impact factor: 8.739

4.  The NSAID glafenine rescues class 2 CFTR mutants via cyclooxygenase 2 inhibition of the arachidonic acid pathway.

Authors:  Graeme W Carlile; Qi Yang; Elizabeth Matthes; Jie Liao; Véronique Birault; Helen F Sneddon; Darren L Poole; Callum J Hall; John W Hanrahan; David Y Thomas
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

5.  The mitochondrial complex I activity is reduced in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function.

Authors:  Angel G Valdivieso; Mariángeles Clauzure; María C Marín; Guillermo L Taminelli; María M Massip Copiz; Francisco Sánchez; Gustavo Schulman; María L Teiber; Tomás A Santa-Coloma
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.